Julie Vackova - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2017	1
2018	2
2019	1
2020	1
2021	1

Page 1

Abrogation of IFN-γ Signaling May not Worsen Sensitivity to PD-1/PD-L1 Blockade.

Vackova J, Piatakova A, Polakova I, Smahel M. Vackova J, et al. Int J Mol Sci. 2020 Mar 6;21(5):1806. doi: 10.3390/ijms21051806. Int J Mol Sci. 2020. PMID: 32155707 Free PMC article.

Establishment and characterization of a mouse tumor cell line with irreversible downregulation of MHC class I molecules.

Lhotakova K, Grzelak A, Polakova I, Vackova J, Smahel M. Lhotakova K, et al. Among authors: vackova j. Oncol Rep. 2019 Dec;42(6):2826-2835. doi: 10.3892/or.2019.7356. Epub 2019 Oct 4. Oncol Rep. 2019. PMID: 31638243

Experimental Combined Immunotherapy of Tumours with Major Histocompatibility Complex Class I Downregulation.

Grzelak A, Polakova I, Smahelova J, Vackova J, Pekarcikova L, Tachezy R, Smahel M. Grzelak A, et al. Among authors: vackova j. Int J Mol Sci. 2018 Nov 21;19(11):3693. doi: 10.3390/ijms19113693. Int J Mol Sci. 2018. PMID: 30469401 Free PMC article.

The effect of clinically relevant doses of immunosuppressive drugs on human mesenchymal stem cells.

Javorkova E, Vackova J, Hajkova M, Hermankova B, Zajicova A, Holan V, Krulova M. Javorkova E, et al. Among authors: vackova j. Biomed Pharmacother. 2018 Jan;97:402-411. doi: 10.1016/j.biopha.2017.10.114. Epub 2017 Nov 6. Biomed Pharmacother. 2018. PMID: 29091890

CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade.

Vackova J, Polakova I, Johari SD, Smahel M. Vackova J, et al. Cancers (Basel). 2021 Apr 16;13(8):1935. doi: 10.3390/cancers13081935. Cancers (Basel). 2021. PMID: 33923750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results